SAB Biotherapeutics, Inc 10-Q for FY2022 Q3
SAB Biotherapeutics, Inc. (SABS)
10-Q
2022-11-14
For: 2022-09-30
View Original
Added on
April 10, 2026
About this 10-Q
SAB Biotherapeutics, Inc filed this 10-Q on November 14, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $3.59M
- down 75.5% from $14.68M a year earlier
- Net loss
- $7.08M
- compared with a net loss of $4.06M a year earlier
- Diluted EPS
- -$0.16
- compared with -$0.16 a year earlier